X4 Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.085; its P/E ratio is ―; X4 Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 600.00K	$ 563.00K	-	-	-
Gross Profit	$ 373.00K	$ 295.00K	-	$ 49.00K	$ 49.00K
EBIT	$ -34.27M	$ 93.03M	$ -36.12M	$ -17.21M	$ -645.00K
EBITDA	$ -34.00M	$ 93.22M	$ -36.06M	$ -17.15M	$ -541.00K
Net Income Common Stockholders	$ -36.70M	$ 90.83M	$ -51.77M	$ -19.13M	$ -2.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 134.98M	$ 168.75M	$ 80.87M	$ 114.22M	$ 141.68M
Total Assets	$ 178.16M	$ 210.61M	$ 112.18M	$ 147.26M	$ 173.29M
Total Debt	$ 78.20M	$ 78.23M	$ 58.27M	$ 3.71M	$ 3.96M
Net Debt	$ -56.77M	$ -90.53M	$ -22.59M	$ -110.50M	$ -137.72M
Total Liabilities	$ 118.54M	$ 116.16M	$ 111.15M	$ 96.16M	$ 105.70M
Stockholders Equity	$ 59.62M	$ 94.49M	$ 1.04M	$ 51.10M	$ 67.59M
Cash Flow	-
Free Cash Flow	$ -34.12M	$ 74.59M	$ -33.66M	$ -27.78M	$ -20.84M
Operating Cash Flow	$ -34.03M	$ -30.27M	$ -33.60M	$ -27.75M	$ -20.83M
Investing Cash Flow	$ -15.93M	$ 96.86M	$ -5.32M	$ -4.83M	$ -5.16M
Financing Cash Flow	-	$ 20.16M	-	$ 97.00K	$ 21.20M

Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

Income Statement >

X4 Pharmaceuticals Debt to Assets

Balance Sheet >

X4 Pharmaceuticals Cash Flow

Cash Flow >

X4 Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing